CStone Pharmaceuticals Reports 2019 Annual Financial Results HealthCare March 26, 2020 CStone Pharmaceuticals (“CStone”; Stock Code: 2616.HK), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology (IO) therapies and…
